PANews reported on March 25 that, according to the Wall Street Journal, Trump plans to appoint Zuckerberg, Huang, and Ellison to his Technology Advisory CouncilPANews reported on March 25 that, according to the Wall Street Journal, Trump plans to appoint Zuckerberg, Huang, and Ellison to his Technology Advisory Council
Trump plans to appoint Zuckerberg, Huang, and Ellison to his Science and Technology Advisory Committee.
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
PANews reported on March 25 that, according to the Wall Street Journal, Trump plans to appoint Zuckerberg, Huang, and Ellison to his Technology Advisory Council.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Triple-A Integrates with Circle Payments Network to Support Cross-Border Stablecoin Settlement
Triple-A, a licensed global financial institution, announced that it has integrated with Circle Payments Network (CPN), operated by Circle Technology Services,
Share
Globalfintechseries2026/03/25 22:33
Trump's airport move just laid bare a massive MAGA lie: columnist
After months of saying that ICE agents need to wear masks so they don't get doxxed, President Donald Trump said this week that they should not wear masks while
Share
Rawstory2026/03/25 23:22
Sarepta Therapeutics (SRPT) Stock Climbs Following Positive siRNA Muscular Dystrophy Trial Results
Sarepta (SRPT) stock rises on positive Phase 1/2 siRNA trial data showing muscle delivery, biomarker activity, and safety in rare muscular dystrophy programs. The
Share
Blockonomi2026/03/25 23:05
